Developmental Research Program

发展研究计划

• 批准号: 10251119
• 负责人: ANIL K SOOD
• 金额: $ 7.44万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-22 至 2023-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10251119
• 关键词: Address; Area; Award; Basic Science; Budgets; Cancer Center; Clinical; Clinical Investigator; Clinical Research; Collaborations; Communities; Data; Development; Discipline; Doctor of Medicine; Early Diagnosis; Early treatment; Financial Support; Funding; Future; Goals; Grant; Human; Institution; Leadership; Malignant neoplasm of ovary; Medical center; Mentorship; Ovarian; Peer Review; Plant Roots; Population Research; Prevention; Program Research Project Grants; Publications; Publishing; Research; Research Personnel; Research Project Grants; Resources; Rest; Scientist; Specimen; Techniques; Texas; Translational Research; Work; anticancer research; design; innovation; novel; ovarian cancer prevention; patient population; programs; recruit; sound; supportive environment; translational study

Developmental Research Program SUMMARY/ABSTRACT The purpose of the Developmental Research Program (DRP) is to fund promising projects by investigators whose current work may not focus exclusively on ovarian cancer, but who propose highly innovative translational studies of ovarian cancer that could become full SPORE projects or compete successfully for funding outside of the SPORE. The DRP provides a unique venue for making available significant financial support, and for demonstrating active institutional support, through a program that is rapidly responsive to new ideas or initiatives. Moreover, this program is rooted in a spirit of collaboration espoused by the SPORE investigators, who have an extensive track-record of bringing investigators from other disciplines into ovarian cancer research. The strength of the DRP rests in its ability to make available financial support needed to access all the critical expertise and resources within the entire SPORE. This will allow us to develop collaborative, multi-investigator, multi-institutional research projects with the support of innovative, investigator-initiated projects that have the potential to flourish into reliable and productive translational research projects that make a path from basic and/or population research projects into research focused on human clinical specimens/patient populations. Over the course of the previously-funded Ovarian SPORE grants since 2000, we have supported 48 DRPs. Overall, 14 former recipients of DRPs have received peer-reviewed funding in ovarian cancer as PI, Co- PI or Co-Investigator with eight as PIs (three DOD, two R01, one R21, one R03 and two CPRIT). Two recipients have been awarded OCRF funds (one Multi-Investigator Award and one Liz Tilberis Scholar). More recently, four recipients have been awarded six peer-reviewed ovarian cancer grants as PI (three R01, one R21, two CPRIT) and one Liz Tilberis Scholar award from the OCRF. Overall, recipients have published 281 peer-reviewed publications regarding ovarian cancer (38 specific to their DRP project) since receiving a DRP award. Additionally, six former awardees have participated in full SPORE projects after completing a DRP project.

发展研究计划摘要/摘要 发展研究计划 (DRP) 的目的是资助有前途的项目 研究人员目前的工作可能不仅仅专注于卵巢癌，但他们强烈建议 卵巢癌的创新转化研究可能成为完整的 SPORE 项目或竞争 成功获得 SPORE 之外的资金。 DRP 提供了一个独特的场所来提供 通过一项计划提供大量财政支持，并展示积极的机构支持 对新想法或举措迅速做出反应。此外，该计划植根于以下精神： SPORE 调查人员拥护合作，他们拥有广泛的追踪记录 来自其他学科的研究人员参与卵巢癌研究。 DRP 的力量在于其 有能力提供获取所有关键专业知识和资源所需的财务支持 整个孢子。这将使我们能够开展协作、多研究者、多机构合作 在创新的、研究者发起的项目的支持下开展的研究项目，这些项目有可能 蓬勃发展为可靠且富有成效的转化研究项目，从基础和/或 人口研究项目转向以人类临床标本/患者群体为重点的研究。超过 自 2000 年以来，在之前资助的 Ovarian SPORE 拨款过程中，我们已支持了 48 个 DRP。 总体而言，14 名前 DRP 接受者作为 PI、Co- 获得了卵巢癌领域的同行评审资助。 PI 或联合研究员，有 8 名 PI（3 位 DOD、2 位 R01、1 位 R21、1 位 R03 和 2 位 CPRIT）。二 获奖者已获得 OCRF 基金（一项多研究者奖和一项 Liz Tilberis 学者奖）。 最近，四名获奖者作为 PI 获得了六项同行评审的卵巢癌资助（其中三项 R01、一项 R21、两项 CPRIT) 和一项来自 OCRF 的 Liz Tilberis 学者奖。总体而言，接收者有 发表了 281 篇有关卵巢癌的同行评审出版物（其中 38 篇专门针对其 DRP 项目） 自从获得 DRP 奖项以来。此外，六名前获奖者参与了完整的 SPORE 项目 完成 DRP 项目后。